World's Best Scientists 2026 revealed!
Award Badge
Microbiology
USA
2026

D-Index & Metrics

Microbiology

D-Index
115
Citations
46215
World Ranking
194
National Ranking
89

Medicine

D-Index
115
Citations
46690
World Ranking
4566
National Ranking
2479

Thomas C. Merigan publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Thomas C. Merigan sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 529 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Thomas C. Merigan D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas C. Merigan sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 115 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Microbiology in United States Leader Award
  • 2025 - Research.com Microbiology in United States Leader Award
  • 1995 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 1981 - Member of the National Academy of Medicine (NAM)
  • 1972 - Fellow of John Simon Guggenheim Memorial Foundation
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Thomas C. Merigan is affiliated with Stanford University in the United States. Their work primarily spans the fields of Medicine and Immunology and Microbiology, with notable focus on Infectious Diseases and Virology. The scientist's research interests are closely tied to HIV/AIDS drug development and treatment, as well as broader HIV research and interventions.

Among the documented publications, Thomas C. Merigan is credited for the paper titled "Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection", published in 2020. This work was disseminated through the UNC Libraries publication venue.

Throughout their research career, they have collaborated with several co-authors, reflecting an interdisciplinary and cooperative approach. Frequent collaborators include:

  • Gregory K. Robbins
  • Victor De Gruttola
  • Robert W. Shafer
  • Laura Smeaton
  • Sally Snyder

Thomas C. Merigan's presence in academic venues is predominantly recorded in UNC Libraries, which serves as a platform for their published work.

The scientist's academic focus is also evident in the main topics they have extensively explored, such as:

  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions

Recognition for their contributions to science includes several awards and memberships in prestigious organizations. Thomas C. Merigan was named a Fellow of the American Association for the Advancement of Science (AAAS) in 1995. They have been a Member of the National Academy of Medicine (NAM) since 1981 and a Fellow of the John Simon Guggenheim Memorial Foundation since 1972. Additionally, they are a Member of the Association of American Physicians.

Best Publications

  • Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection: A Controlled Trial in Persons with Fewer Than 500 CD4-Positive Cells per Cubic Millimeter

    Paul A. Volberding;Stephen W. Lagakos;Matthew A. Koch;David K. Booth

  • A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

    Scott M. Hammer;David A. Katzenstein;Michael D. Hughes;Holly Gundacker

  • Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.

    Ann C. Collier;Robert W. Coombs;David A. Schoenfeld;Roland L. Bassett

  • Extensive polymorphisms observed in HIV–1 clade B protease gene using high–density oligonucleotide arrays

    Michael J. Kozal;Nila Shah;Naiping Shen;Robert Yang

  • The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection a double-blind, placebo-controlled trial

    M. A. Fischl;D. D. Richman;N. Hansen;A. C. Collier

  • Recombinant interferon-gamma increases HLA-DR synthesis and expression.

    T Y Basham;T C Merigan

  • Effect of Human Leukocyte Interferon on Hepatitis B Virus Infection in Patients with Chronic Active Hepatitis

    Harry B. Greenberg;Richard B. Pollard;Larry I. Lutwick;Peter B. Gregory

  • A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy

    John D. Baxter;Douglas L. Mayers;Deborah N. Wentworth;James D. Neaton

  • The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter

    David A. Katzenstein;Scott M. Hammer;Michael D. Hughes;Holly Gundacker

  • Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.

    Jordan U. Gutterman;Seymour Fine;Jorge Quesada;Sandra J. Horning

  • A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation.

    Thomas C. Merigan;Dale G. Renlund;Susan Keay;Michael R. Bristow

  • Recombinant Gamma Interferon Induces HLA-DR Expression on Cultured Human Keratinocytes

    Teresa Y. Basham;Brian J. Nickoloff;Thomas C. Merigan;Vera B. Morhenn

  • Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

    Gregory K. Robbins;Victor De Gruttola;Robert W. Shafer;Laura M. Smeaton

  • A Controlled Trial Comparing Continued Zidovudine with Didanosine in Human Immunodeficiency Virus Infection

    Kahn Jo;Lagakos Sw;Richman Dd;Cross A

  • Human leukocyte Interferon for the treatment of herpes zoster in patients with cancer.

    Thomas C. Merigan;Kenneth H. Rand;Richard B. Pollard;Paul S. Abdallah

  • A Randomized Controlled Trial of a Reduced Daily Dose of Zidovudine in Patients with the Acquired Immunodeficiency Syndrome

    Margaret A. Fischl;Corette B. Parker;Carla Pettinelli;Michael Wulfsohn

  • Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.

    Hannah A. Valantine;Shao-Zhou Gao;Santosh G. Menon;Dale G. Renlund

  • Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

    Ronald T. Mitsuyasu;Thomas C. Merigan;Andrew D Carr;Jerome A. Zack

  • The Effect of High-Dose Saquinavir on Viral Load and CD4+ T-Cell Counts in HIV-Infected Patients

    Jonathan M. Schapiro;Mark A. Winters;Fran Stewart;Bradley Efron

  • Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma

    Thomas C. Merigan;Karol Sikora;James H. Breeden;Ronald Levy

Frequent Co-Authors

Mark A. Winters
Mark A. Winters Stanford University
David Katzenstein
David Katzenstein Stanford University
Robert W. Shafer
Robert W. Shafer Stanford University
Richard B. Pollard
Richard B. Pollard University of California, Davis
William S. Robinson
William S. Robinson Stanford University
Mark Holodniy
Mark Holodniy Stanford University
Martin S. Hirsch
Martin S. Hirsch Harvard Medical School
Ann M. Arvin
Ann M. Arvin Stanford University
Douglas D. Richman
Douglas D. Richman University of California, San Diego
David A. Stevens
David A. Stevens Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in expanding their expertise beyond traditional microbiology, exploring related online degrees can open doors to diverse career pathways. One growing field is health information management, which combines healthcare knowledge with data analytics. Understanding the health information management job description and salary offers insight into opportunities that balance patient care with information science.

When considering education, it is important to choose a program with reputable accreditation. For example, the accredited online health information management degree cahiim programs ensure that students receive industry-recognized training, which enhances employability and expertise in the healthcare sector.

For those seeking quicker entry into healthcare administration, accelerated options like the accelerated medical billing and coding certificate online offer practical skills in managing medical records and billing systems. These certificates can complement a microbiology background by adding essential administrative competencies.

Finally, numerous medical programs online are available that allow students to tailor their education to specific interests within health and science. Combining microbiology with relevant online medical degrees can lead to versatile and rewarding career paths in healthcare, research, and technology.

Best Scientists Citing Thomas C. Merigan

Trending Scientists

Recently Published Articles